PHARMACEUTICAL AND BIOPHARMACEUTICAL PATENTS: AN OPPORTUNITY FOR FARMERGING COUNTRIES

Authors

  • Karina Fernandes de Oliveira Universidade Presbiteriana Mackenzie
  • Gabriel Guerra da Silva Freire Universidade Presbiteriana Mackenzie
  • Igor Polezi Munhoz IFSP - Instituto Federal de Educação, Ciência e Tecnologia de São Paulo
  • Alessandra Cristina Santos Akkari Universidade Presbiteriana Mackenzie

DOI:

https://doi.org/10.24212/2179-3565.2018v9i3p135-148

Keywords:

Pharmaceutical Industry, Biopharmaceutical Industry, Innovation, Pharmerging countries.

Abstract

Countries with emerging pharmaceutical market (pharmerging countries) has gained prominence in the international scenario because they are identified as the future responsible for the sustainable growth of the new medicines sale. In this work, a technological and industrial mapping was developed through the analysis of patent data extracted from the Derwent World Patent Index, as well as an association with R&D reports. Pharmerging countries were not represented by the industries that most invest in R&D, nor do they stand out in patent protection, poiting to low exploitation of their markets and inexpressive innovation indices. It is suggested that the pharmerging countries adopt public policies aimed at the innovation generation, especially in the biopharmaceutical segment that has proven to have much to be explored, in order to gain a competitive advantage

Downloads

Published

2018-10-26

Issue

Vol. 9 No. 3 (2018): SET ( 2018 )/ FEV( 2019 )

Section

Papers

License

This Journal is licensed under a Creative Commons Attribution-Non Commercial-No Derivers 4.0 International license.

1.The author (s) authorize the publication of the article in the journal;

2.The author (s) warrant that the contribution is original and unpublished and is not in the process of being evaluated in other journal (s);

3. The journal is not responsible for the opinions, ideas and concepts emitted in the texts, as they are the sole responsibility of its author (s);

4. The editors are entitled to make textual adjustments and to adapt the articles to the standards of publication.